CVS to pay $315M over unlawful opioid prescription claims

Published: 13:29 EDT, 14 October 2026 | Updated: 13:29 EDT, 14 October 2026

CVS Pharmacy Inc. has agreed to pay $315 million to settle allegations it unlawfully filled unnecessary opioid prescriptions. The settlement resolves a 2024 US Justice Department lawsuit accusing the pharmaceutical giant of dispensing massive quantities of opioids that fueled America’s addiction crisis since 2013. Under the settlement, CVS also agreed to new safeguards with the Drug Enforcement Administration (DEA) to ensure opioids and other controlled drugs are only filled when medically necessary. It’s the latest effort by the federal government to hold accountable companies that officials have alleged helped fuel the US addiction and overdose crisis. ‘Today’s settlement is a significant milestone in the Justice Department’s efforts to combat the opioid epidemic by cracking down on pharmacies ​who unlawfully fulfill prescriptions for controlled substances,’ Associate Attorney General Stanley Woodward said in a statement. In a statement to the Daily Mail, CVS said its pharmacists are ‘highly trained in the safe and appropriate use of all medications.’ ‘We’ve implemented best-in-class and first-of-their-kind programs to help our pharmacists make the best decisions on behalf of patients,’ a spokesperson said. ‘We strongly disagree with the claims made in this case, and our settlement with the DOJ admits no wrongdoing.

We’re pleased to move forward and put this litigation behind us.’ The Justice Department’s lawsuit, which was filed in federal court in Rhode ​Island, began as ⁠a whistleblower complaint brought by a former CVS employee. The lawsuit accused CVS of filling prescriptions for excessive amounts of opioids and other drugs, including those from ‘pill mills,’ where doctors handed out large amounts of addictive painkillers without a legitimate medical reason. It also accused the company of imposing ‘unsafe performance targets and staffing levels’ that ‘pressured pharmacists to fill prescriptions as quickly as possible’ without checking whether they were valid. The prescriptions were often billed to and reimbursed by Medicaid and other federal healthcare programs, the lawsuit says. Over the past decade, drugmakers, wholesalers, pharmacies and other companies have agreed to more than $50 billion in opioid-related settlements with US governments. Most of the settlement money is intended to help address the addiction crisis, which has been linked to more than 100,000 deaths in some years, although fatalities have fallen sharply in recent years.

According to recent data from the Centers for Disease Control and Prevention (CDC), prescription opioid overdose deaths rose from 3,442 in 1999 to 17,029 in 2017. From 2017 to 2023, there was an overall decline to 13,026. The majority of the deals have been reached with state and local governments, but the federal government has also struck several agreements, including with pharmacy chains Walgreens and Walmart in the past two years. Opioids are prescription painkillers that act similarly to heroin in the body, producing pain relief and a euphoric high that can be highly addictive.

They work by attaching to proteins called opioid receptors on nerve cells in the brain, spinal cord and gut. When opioids bind to these receptors, they block pain signals and trigger the release of dopamine, a brain chemical linked to pleasure and reward. This creates feelings of relaxation and euphoria, which can make people want to keep taking the drugs to recreate the pleasurable effects. However, opioids are addictive and can cause harmful side effects, including nausea, constipation, confusion and drowsiness. Misusing them can also slow breathing, depriving the brain of oxygen in a condition called hypoxia.

In severe cases, this can lead to brain damage, coma or death. Drugs such as Vicodin, OxyContin and Percocet are typically prescribed for short-term pain relief after major surgery, serious injuries or dental procedures. The lawsuit noted ​that CVS had been among the top dispensers of opioids in the nation, selling over 12 billion doses of the drugs from 2015 ​to 2020. It also noted that CVS is the largest pharmacy chain in the nation. It is wholly-owned by the sixth largest corporation in the US, which reported over $116 billion in Pharmacy & Consumer Wellness revenue for 2023. CVS operates more than 9,000 pharmacies and fills more than a billion prescriptions each year.

Sorry we are not currently accepting comments on this article.